Literature DB >> 12124307

Glucuronidation and sulfation of the tea flavonoid (-)-epicatechin by the human and rat enzymes.

Jaya Bharathi Vaidyanathan1, Thomas Walle.   

Abstract

(-)-Epicatechin (EC) is one of the flavonoids present in green tea, suggested to have chemopreventive properties in cancer. However, its bioavailability is not clearly understood. In the present study, we determined the metabolism of EC, focusing on its glucuronic acid and sulfate conjugation using human liver and intestinal microsomes and cytosol as well as recombinant UDP-glucuronosyltransferase (UGT) and sulfotransferase (SULT) isoforms in comparison with that occurring in the rat. Surprisingly, EC was not glucuronidated by the human liver and small intestinal microsomes. There was also no evidence of glucuronidation by human colon microsomes or by recombinant UGT1A7, which is not present in the liver or intestine. Interestingly, in the rat liver microsomes EC was efficiently glucuronidated with the formation of two glucuronides. In contrast, the human liver cytosol efficiently sulfated EC mainly through the SULT1A1 isoform. For the intestine, both SULT1A1 and SULT1A3 contributed. Other SULT isoforms contributed little. High-performance liquid chromatography of the sulfate conjugates showed one major sulfatase-sensitive peak with all tissues. An additional minor sulfatase-resistant peak was formed by the liver and intestinal cytosol as well as with SULT1A1 but not by the Caco-2 cytosol and SULT1A3. In the rat, EC sulfation was considerably less efficient than in the human liver. These results indicate that sulfation is the major pathway in EC metabolism in the human liver and intestine with no glucuronidation occurring. There was also a large species difference both in glucuronidation and sulfation of EC between rats and humans.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12124307     DOI: 10.1124/dmd.30.8.897

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  29 in total

1.  Enzymatic synthesis of substituted epicatechins for bioactivity studies in neurological disorders.

Authors:  Jack W Blount; Mario Ferruzzi; Dan Raftery; Giulio M Pasinetti; Richard A Dixon
Journal:  Biochem Biophys Res Commun       Date:  2011-12-07       Impact factor: 3.575

Review 2.  Bioavailability challenges associated with development of anti-cancer phenolics.

Authors:  Song Gao; Ming Hu
Journal:  Mini Rev Med Chem       Date:  2010-06       Impact factor: 3.862

3.  Glucuronidation and methylation of procyanidin dimers b2 and 3,3″-di-o-galloyl-b2 and corresponding monomers epicatechin and 3-o-galloyl-epicatechin in mouse liver.

Authors:  Suraj P Shrestha; John A Thompson; Michael F Wempe; Mallikarjuna Gu; Rajesh Agarwal; Chapla Agarwal
Journal:  Pharm Res       Date:  2011-11-09       Impact factor: 4.200

4.  Nanoencapsulation enhances epigallocatechin-3-gallate stability and its antiatherogenic bioactivities in macrophages.

Authors:  Jia Zhang; Shufang Nie; Shu Wang
Journal:  J Agric Food Chem       Date:  2013-09-10       Impact factor: 5.279

5.  Intestinal transit and systemic metabolism of apple polyphenols.

Authors:  Kathrin Kahle; Michael Kempf; Peter Schreier; Wolfgang Scheppach; Dieter Schrenk; Tanja Kautenburger; Dorothée Hecker; Wolfgang Huemmer; Matthias Ackermann; Elke Richling
Journal:  Eur J Nutr       Date:  2010-12-24       Impact factor: 5.614

6.  Subcellular localization of flavonol aglycone in hepatocytes visualized by confocal laser scanning fluorescence microscope.

Authors:  Rie Mukai; Yasuhito Shirai; Naoaki Saito; Ken-Ichi Yoshida; Hitoshi Ashida
Journal:  Cytotechnology       Date:  2009-07-01       Impact factor: 2.058

Review 7.  Regioselective sulfation and glucuronidation of phenolics: insights into the structural basis.

Authors:  Baojian Wu; Sumit Basu; Shengnan Meng; Xiaoqiang Wang; Ming Hu
Journal:  Curr Drug Metab       Date:  2011-11       Impact factor: 3.731

Review 8.  The challenge of developing green tea polyphenols as therapeutic agents.

Authors:  C Huo; S B Wan; W H Lam; L Li; Z Wang; K R Landis-Piwowar; D Chen; Q P Dou; T H Chan
Journal:  Inflammopharmacology       Date:  2008-10       Impact factor: 4.473

Review 9.  Tea and health: studies in humans.

Authors:  Naghma Khan; Hasan Mukhtar
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

10.  Intestinal absorption of aloin, aloe-emodin, and aloesin; A comparative study using two in vitro absorption models.

Authors:  Mi-Young Park; Hoon-Jeong Kwon; Mi-Kyung Sung
Journal:  Nutr Res Pract       Date:  2009-03-31       Impact factor: 1.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.